
 
Lily Yang, MD, PhD
Dr. Yang's CV (PDF)
| Primary Appointment |
 |
Associate Professor, Surgical Oncology Research, Department of Surgery,
Emory University School of Medicine |
| Secondary Appointment |
 |
Associate Professor, Department of Radiology, Emory University School of Medicine |
| Joint Appointments |
 |
Assistant Professor, Department of Hematology/Oncology, Winship Cancer Institute |
 |
Faculty Member; Graduate Programs in Biochemistry, Cell and Developmental Biology (BCDB) and Molecular Systemic Pharmacology (MSP); Emory University School of Medicine |
| Telephone |
 |
404.778.4269 |
| Education |
 |
MD, Department of Medicine, West China University of Medical Sciences,
Chengdu, Sichuan Province, China, 1978-1983 |
 |
Master of Medicine, Microbiology
and Immunology, Institute of Epidemiology and Microbiology, Chinese Academy
of Preventive Medicine, Beijing, China, 1983-1986 |
 |
PhD, Program in Molecular
and Cell Biology & Biochemistry, Brown University, Providence, RI,
1988-1993 |
| Postgraduate Training |
 |
Research Associate, Department of Immunology, Beijing Institute for Cancer
Research, Beijing, China, 1986-1988 |
 |
Postdoctoral Associate, Brown University-Rhode
Island Hospital, 1993 |
 |
Research Associate and Director of Animal Study,
University of Southern California School of Medicine, Los Angeles, CA,
1993-1995 |
 |
Research Associate, Emory, 1995-1996 |
 |
Research Fellow, Group Leader
For Anti-Angiogenesis Pre-Clinical Study, Aventis Gencell, Hayward, CA,
1998-1999 |
| Honors and Awards |
 |
Avon Scholar Award for Breast Cancer Research, 2001-2002 |
 |
NIH First Award, 1999-2005 |
 |
Monthly Feature, NCI Alliance for Nanotechnology in Cancer, April 2006 |
| Current Editorial Boards |
 |
Apoptosis |
 |
Nanomedicine |
| Current Organizational Memberships |
 |
American Association for Cancer Research |
 |
American Academy of Nanomedicine, Fellow |
 |
Scientific Peer Review Panel Member, Breast Cancer Research Program, Department of Defense |
 |
Molecular Genetics #3, Pathobiology #4, Pathobiology #2, Synergistic Idea Awards (SIA-3) Panel |
 |
Pathogenesis Committee, California Breast Cancer Research Program |
 |
Society of Molecular Imaging |
| Current Research Interests |
The development of novel approaches for detection and treatment of human cancer, with specific projects including: |
|
|
 |
Targeting the inhibitor of the apoptosis family of proteins, such as survivin and XIAP, for cancer therapy. |
 |
Studying signal pathways and molecular mechanisms that confer aggressive behavior of CD44+ breast cancer cells (putative breast cancer stem cells). |
 |
Investigating molecular pathways promoting the progression of breast cancer from ductal carcinoma in situ to invasive breast cancer. |
 |
The development of multifunctional nanoparticles for cancer detection using targeted tumor optical and MR imaging, drug delivery, and monitoring therapeutic responses. |
| Year Joined Emory as a Faculty
Member |
 |
1997 |
return to top
|